Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 12, 2009

View Archived Issues

Imatinib prevents, reverses diabetes in nonobese mice

Lower doses of PfCP2.9 malaria vaccine candidate tested in phase I study

Device captures metastatic cells from circulation and delivers apoptotic signal

MenACWY-TT meningococcal vaccine immunogenic in adolescents

FDA approves Prism's NDA for Nexterone in ventricular fibrillation and tachycardia

Clinical Data presents results from Vilazodone and Stedivaze trials

Fasgen and Centocor sign research and license agreement in oncology

Synta and Roche enter agreement for small-molecule drugs targeting CRACM channels

Novel anti-EGFR family member antibodies described in recent patent

Xenon discloses new sodium channel blockers with analgesic properties

Astellas claims new N-type calcium channel blockers for alleviating pain

Novartis imparts novel chemokine CXCR2 receptor antagonists in recent patent

Recent Argenta Discovery patent discloses new HNE inhibitors for respiratory disorders

Quark doses first patient in phase I/II QPI-1002 trial for delayed graft function

Aegera initiates phase II AEG-35156 trial in non-small cell lung cancer

Michael J. Fox Foundation awards grant to Arcadia for development of ERbeta agonists in PD

FDA grants approval to Ark to initiate patient recruitment into phase III trial of Trinam

BioMimetic completes enrollment into clinical trial of Augment Bone Graft

Sinclair and Graceway sign U.S. agreement for Atopiclair for atopic dermatitis

FDA extends PDUFA action date for Ipsen's Reloxin BLA for glabellar lines

PAION's sedative CNS-7056 meets target profile in proof-of-concept study

Juvaris presents positive data from JVRS-100 adjuvanted flu vaccine trial

RegeneRx reports phase II RGN-137 results in chronic pressure ulcers

SCY-635 demonstrates proof-of-concept in HCV-infected adults

Sucampo completes enrollment in cobiprostone trial for NSAID-induced ulcers

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...